These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4612606)

  • 1. Neutralization, immunofluorescence and complement fixation tests in identification of antibody to a herpesvirus type 2-induced, tumor-specific antigen in sera from squamous cervical carcinoma.
    Aurelian L; Strandberg JD; Marcus RL
    Prog Exp Tumor Res; 1974; 19():165-81. PubMed ID: 4612606
    [No Abstract]   [Full Text] [Related]  

  • 2. Soluble membrane antigens of lip and cervical carcinomas: reactivity with antibody for herpesvirus nonvirion antigens.
    Hollinshead AC; Tarro G
    Science; 1973 Feb; 179(4074):698-700. PubMed ID: 4734354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of antibody to a virus-induced tumor-associated antigen (AG-4) in Japanese sera from patients with cervical cancer and controls.
    Kawana T; Cornish JD; Smith MF; Aurelian L
    Cancer Res; 1976 Jun; 36(6):1910-4. PubMed ID: 1268845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody to HSV-2 induced tumor specific antigens in serums from patients with cervical carcinoma.
    Aurelian L; Schumann B; Marcus RL; Davis HJ
    Science; 1973 Jul; 181(4095):161-4. PubMed ID: 4711734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to surface antigens of herpesvirus type 1- and type 2-infected cells among women with cervical cancer and control women.
    Smith JW; Lowry SP; Melnick JL; Rawls WE
    Infect Immun; 1972 Mar; 5(3):305-10. PubMed ID: 4344217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to herpesvirus nonvirion antigens in squamous carcinomas.
    Hollinshead AC; Lee O; Chretien PB; Tarpley JL; Rawls WE; Adam E
    Science; 1973 Nov; 182(4113):713-5. PubMed ID: 4752210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virions and antigens of herpes virus type 2 in cervical carcinoma.
    Aurelian L
    Cancer Res; 1973 Jun; 33(6):1539-47. PubMed ID: 4352393
    [No Abstract]   [Full Text] [Related]  

  • 8. Herpesvirus type 2-induced, tumor-specific antigen in cervical carcinoma.
    Aurelian L; Davis HJ; Julian CG
    Am J Epidemiol; 1973 Jul; 98(1):1-9. PubMed ID: 4131112
    [No Abstract]   [Full Text] [Related]  

  • 9. Bovine herpesvirus-5 (DN599) antigens in cells derived from bovine ocular squamous cell carcinoma.
    Anson MA; Benfield DA; McAdaragh JP
    Can J Comp Med; 1982 Jul; 46(3):334-7. PubMed ID: 6751509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgM antibody to a tumor-associated antigen (AG-4) induced by herpes simplex virus type 2: its use in location of the antigen in infected cells.
    Aurelian L; Smith MF; Cornish DJ
    J Natl Cancer Inst; 1976 Mar; 56(3):471-7. PubMed ID: 176392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viruses and gynecologic cancers: herpesvirus protein (ICP 10/AG-4), a cervical tumor antigen that fulfills the criteria for a marker of carcinogenicity.
    Aurelian L; Kessler II; Rosenshein NB; Barbour G
    Cancer; 1981 Jul; 48(2 Suppl):455-71. PubMed ID: 7023662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity between herpesvirus type 2-related soluble cervical tumor cell membrane antigens and matched cancer and control sera.
    Hollinshead A; Lee OB; McKelway W; Melnick JL; Rawls WE
    Proc Soc Exp Biol Med; 1972 Nov; 141(2):688-93. PubMed ID: 4564620
    [No Abstract]   [Full Text] [Related]  

  • 13. Possible role of Herpesvirus hominis, type 2, in human cervical cancer.
    Aurelian L
    Fed Proc; 1972; 31(6):1651-9. PubMed ID: 4351374
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative diagnostic aspects of herpes simplex virus tumor-associated antigens.
    Notter MF; Docherty JJ
    J Natl Cancer Inst; 1976 Sep; 57(3):483-8. PubMed ID: 185398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunomorphological identification of an antigen associated with squamous cell carcinoma of the cervix uteri].
    Ievleva ES; Ermoshina NV; Ageenko AI
    Eksp Onkol; 1988; 10(5):33-5. PubMed ID: 3061778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of herpes simplex virus tumor-associated antigen in uterine cervical cancer tissue: five case studies.
    Notter MF; Docherty JJ; Mortel R; Hollinshead AC
    Gynecol Oncol; 1978 Dec; 6(6):574-81. PubMed ID: 220150
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies of tumor-specific and herpesvirus nonvirion antigens.
    Hollinshead A; Tarro G; Foster WA; Seigel LJ; Jaffurs W
    Cancer Res; 1974 May; 34(5):1122-5. PubMed ID: 4842911
    [No Abstract]   [Full Text] [Related]  

  • 18. Elution of herpes simplex virus-specific cytotoxic antibodies from squamous cell carcinoma of uterine cervix.
    Seth P; Balachandran N
    Nature; 1980 Aug; 286(5773):613-5. PubMed ID: 6250079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpesvirus antigens as markers for cervical cancer.
    Gupta PK; Aurelian L; Frost JK; Carpenter JM; Klacsmann KT; Rosenshein NB; Tyrer HW
    Gynecol Oncol; 1981 Oct; 12(2 Pt 2):S232-58. PubMed ID: 6273263
    [No Abstract]   [Full Text] [Related]  

  • 20. Herpes type-2 virus antigens in human cervical carcinoma.
    Adelusi B; Osunkoya BO; Fabiyi A
    Obstet Gynecol; 1976 May; 47(5):545-8. PubMed ID: 772507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.